RMOC Recommendation: Standardising strengths of high risk, unlicensed oral liquids formulations for anti-TB medicines

Topics: IsoniazidMedication SafetyPyrazinamide · 4 more Rifampicin + IsoniazidRifampicin + Isoniazid + PyrazinamideRMOC recommendations and resourcesUnlicensed medicines · Less

Isoniazid
Medication Safety
Pyrazinamide
Rifampicin + Isoniazid
Rifampicin + Isoniazid + Pyrazinamide
RMOC recommendations and resources
Unlicensed medicines

At the meeting on 26th October 2017 the Regional Medicines Optimisation Committee (North) endorsed the approach put forward by the NHS Pharmaceutical Quality Assurance Committee Sub-Group on Unlicensed Medicines to standardise the strengths of high risk unlicensed oral liquids for anti- TB medicines.

Attachments

RMOC-statement-TB-standardisation-of-products · PDF · 194 KB